The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Innovation in Medical Devices: Cardiovascular implant materials. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, neurostimulation therapy, smart physiotherapy devices, and real-time IR thermographic imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Precision radiotherapy, electric atomisers, and bio-active prosthesis coating are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are bioresorbable stent coating and cryogenic tissue treatment, which are now well established in the industry.
Innovation S-curve for the medical devices industry
Cardiovascular implant materials is a key innovation area in the medical devices industry
Cardiovascular implant materials involve biomaterials that are compatible with the patient’s body and help with the proper functioning of the heart and blood vessels. The materials include metals, alloys, carbons, ceramics, and polymers such as pyrolytic carbon, titanium, stainless steel, and nitinol. Cardiovascular implant materials have properties such as natural corrosion resistance, the capacity to control chemical reactions inside the body, and non-magnetic properties. Titanium and its alloys are utilised frequently in cardiovascular implants due to its strength, inertness, and lack of magnetic characteristics.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 370+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of cardiovascular implant materials.
Key players in cardiovascular implant materials – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Edwards Lifesciences is one of the leading patent filers in the field of cardiovascular implant materials. Some other key patent filers in the field, include Medtronic, Abbott Laboratories, Boston Scientific, and Johnson & Johnson.
In terms of application diversity, Micell Technologies leads the pack, followed by Toray Industries and CorMatrix Cardiovascular. By means of geographic reach, Hellman & Friedman holds the top position, followed by 4C Medical Technologies, and Sino Medical Sciences Technology in the second and third spots, respectively.
The demand for cardiovascular implant materials for the implants market will increase due to the growing burden of the ageing population and the associated cardiovascular disorders. Future advancements will involve the development of materials that are not only compatible but also allow tissue regeneration and long-term usage.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
